Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
Watera C, Ssemwanga D, Namayanja G, Asio J, Lutalo T, Namale A, Sanyu G, Ssewanyana I, Gonzalez-Salazar JF, Nazziwa J, Nanyonjo M, Raizes E, Kabuga U, Mwangi C, Kirungi W, Musinguzi J, Mugagga K, Mbidde EK, Kaleebu P. Watera C, et al. Among authors: kaleebu p. J Antimicrob Chemother. 2021 Aug 12;76(9):2407-2414. doi: 10.1093/jac/dkab159. J Antimicrob Chemother. 2021. PMID: 33993252 Free PMC article.
Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda.
Ndembi N, Lyagoba F, Nanteza B, Kushemererwa G, Serwanga J, Katongole-Mbidde E, Grosskurth H, Kaleebu P; Uganda HIV Drug Resistance Working Group. Ndembi N, et al. Among authors: kaleebu p. AIDS Res Hum Retroviruses. 2008 Jun;24(6):889-95. doi: 10.1089/aid.2007.0317. AIDS Res Hum Retroviruses. 2008. PMID: 18544019
Estimating incidence of HIV infection in Uganda.
Todd J, Lutalo T, Kaleebu P. Todd J, et al. Among authors: kaleebu p. JAMA. 2009 Jan 14;301(2):159-60; author reply 160-1. doi: 10.1001/jama.2008.954. JAMA. 2009. PMID: 19141759 No abstract available.
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Munderi P, Walker AS, Kityo C, Babiker AG, Ssali F, Reid A, Darbyshire JH, Grosskurth H, Mugyenyi P, Gibb DM, Gilks CF; DART/NORA trial teams. Munderi P, et al. HIV Med. 2010 May;11(5):334-44. doi: 10.1111/j.1468-1293.2009.00786.x. Epub 2010 Feb 3. HIV Med. 2010. PMID: 20136661 Free article. Clinical Trial.
399 results